← Back to Search

Cross-Training Program for Cancer Survivors (CAPABLE Trial)

N/A
Recruiting
Led By Jennifer Beebe-Dimmer, MPH, PhD.
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with an invasive cancer
Aged 18 years or older at time of program recruitment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will see if cancer survivors who do a cross-training program improve more in functional performance, body composition, and quality of life compared to those who follow the American Cancer Society guidelines.

Who is the study for?
This trial is for cancer survivors who are 18 or older and have been diagnosed with invasive cancer. They must be cleared by their doctor to join the program, which could include those currently in treatment or those who've finished. Participants need a way to get to the facility on session days.
What is being tested?
The study tests a 12-week cross-training program against current American Cancer Society guidelines for cancer survivors. It aims to see if this new approach can better improve functional performance, body composition, and quality of life.
What are the potential side effects?
Since this is an exercise-based intervention rather than medication, side effects may include muscle soreness, fatigue, and potential injury from physical activity. The intensity will be tailored to each participant's ability.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a cancer that is spreading into surrounding tissues.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Body Composition
Change in Motivation
Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: A 12-week pilot intervention study introducing a high-intensiExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Barbara Ann Karmanos Cancer InstituteLead Sponsor
164 Previous Clinical Trials
9,148 Total Patients Enrolled
Jennifer Beebe-Dimmer, MPH, PhD.Principal Investigator - Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute

Media Library

12 week pilot intervention study Clinical Trial Eligibility Overview. Trial Name: NCT03750981 — N/A
Cancer Survivors Research Study Groups: A 12-week pilot intervention study introducing a high-intensi
Cancer Survivors Clinical Trial 2023: 12 week pilot intervention study Highlights & Side Effects. Trial Name: NCT03750981 — N/A
12 week pilot intervention study 2023 Treatment Timeline for Medical Study. Trial Name: NCT03750981 — N/A
~5 spots leftby May 2025